Vinva Investment Management Ltd Reduces Stake in Colgate-Palmolive (NYSE:CL)

Vinva Investment Management Ltd lowered its position in Colgate-Palmolive (NYSE:CL) by 12.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,339 shares of the company’s stock after selling 10,365 shares during the period. Vinva Investment Management Ltd’s holdings in Colgate-Palmolive were worth $6,749,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Finally, Wintrust Investments LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CL. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, March 14th. UBS Group lowered their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday, March 14th. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Morgan Stanley reduced their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Stock Down 1.4 %

Shares of CL opened at $89.45 on Wednesday. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a market capitalization of $72.59 billion, a PE ratio of 25.41, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock has a fifty day simple moving average of $89.13 and a two-hundred day simple moving average of $94.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm posted $0.87 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.